Exchange: NASDAQ Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic
Current Signal: SELL (auto-tracking)
-1.66% $2.37
America/New_York / 19 apr 2024 @ 16:00
FUNDAMENTALS | |
---|---|
MarketCap: | 903.68 mill |
EPS: | -0.300 |
P/E: | -7.90 |
Earnings Date: | May 07, 2024 |
SharesOutstanding: | 381.30 mill |
Avg Daily Volume: | 2.97 mill |
RATING 2024-04-19 |
---|
B |
Neutral |
RATINGS | ||
---|---|---|
Rating CashFlow: | Strong Buy | |
Return On Equity: | Sell | |
Return On Asset: | Sell | |
DE: | Neutral | |
P/E: | Sell | |
Price To Book: | Neutral |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
Revenue | ||||||
Gr.Profit | ||||||
Ebit | ||||||
Asset | ||||||
Debt |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE -7.90 | sector: PE -3.05 |
PE RATIO: COMPANY / INDUSTRY |
---|
-0.17x |
Company: PE -7.90 | industry: PE 47.78 |
DISCOUNTED CASH FLOW VALUE |
---|
N/A |
N/A |
Expected Trading Range (DAY) |
---|
$ 2.23 - 2.51 ( +/- 5.91%) |
ATR Model: 14 days |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-03-15 | Gorelik Ran | Buy | 22 222 | COMMON SHARES |
2023-03-15 | Gorelik Ran | Sell | 22 222 | RESTRICTED STOCK UNITS |
2024-04-02 | Wagner Adam | Sell | 0 | COMMON SHARES |
2024-04-02 | Wagner Adam | Sell | 45 434 | RESTRICTED STOCK UNITS |
2024-03-15 | Weigensberg Arye | Sell | 24 237 | RESTRICTED STOCK UNITS |
INSIDER POWER |
---|
46.50 |
Last 96 transactions |
Buy: 4 511 377 | Sell: 1 430 605 |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | $2.37 (-1.66% ) |
Volume | 3.87 mill |
Avg. Vol. | 2.97 mill |
% of Avg. Vol | 130.36 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % | Feb 8 - 15:35 | sell | $2.18 | N/A | Active |
---|
Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. It sells cannabis and cannabis products, including dried cannabis, pre-rolls, edibles, concentrates, and cannabis extracts through wholesale and direct-to-client channels under its wellness platform, PEACE NATURALS; and operates under adult-use brands, Spinach. It also exports dried cannabis and cannabis oils to Germany, Israel, and Australia. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.